GB SCIENCES INC. GBLX news, videos and press releases
For more news please use our advanced search feature.
GB SCIENCES INC. GBLX - More news...
GB SCIENCES INC. GBLX - More news...
- GB Sciences Closes the Sale of GB Sciences Louisiana Cannabis Business to Wellcana Plus and Retains the Benefit of IP Developed Under GB Sciences Louisiana's Master Research and Development Agreement
- The Closing Date of GB Sciences' Sale of GB Sciences Louisiana LLC Is Delayed
- GB Sciences Welcomes Esteemed Patent and Intellectual Property Attorney, Mr. Edmond DeFrank, to Its Board of Directors
- GB Sciences' Chief Science Officer Featured on the Cover of the Marijuana Business Magazine
- GB Sciences Sells Its Louisiana Medical Marijuana Business At A $32 Million Total Valuation
- U.S. Drug Enforcement Agency to Expand Cannabis Research: GB Sciences Submitted One of Thirty-Three Applications to Become a DEA-Registered Cannabis Supplier to U.S. Marijuana Researchers
- GB Sciences Names Darin Carpenter as Executive Vice President of Cannabis Operations
- GB Sciences Prepares To Launch New Products In Louisiana With Educational Seminars For Doctors And Pharmacists
- History Made! GB Sciences Louisiana Announces Medical Cannabis Products Now for Sale for First Time in State History
- GB Sciences Files Novel Patent Application For Chronic Pain Treatments Based On Proprietary Cannabis-Derived Formulations
- GB Sciences Obtains Exclusive License for Patented Oral Thin Film Technology Containing Cannabis and Hemp-Derived Ingredients
- GBS Global Biopharma and National Research Council of Canada Begin Preclinical Studies on Chronic-Neuropathic Pain Therapies
- GB Sciences Prepares to Triple Production Capabilities in Its Las Vegas Facility
- GB Sciences Louisiana Receives All Approvals and Announces the Opening of the Full Tissue Propagation Cannabis Cultivation at LSU Agricultural Center
- Today: GB Sciences' Use of Controlled Cultivation, Product Formulations and Research Will Be Presented by Dr. Dominick Monaco at Cannabis Conference 2019, As Featured on Cover of Cannabis Business Times
- GB Sciences Study Shows Nevada's Cannabis Strain Names Have No Correlation to Active Ingredients
- In Case You Missed It: GB Sciences Approved For Full Operations In Main LSU AgCenter Production Facility
- Louisiana Agriculture Commissioner Approves GB Sciences To Begin Full Operations In Main LSU AgCenter Production Facility
- GB Sciences Launches Global Expansion in Canada with GBS Global Biopharma, Inc.
- GB Sciences Supports the Position of LSU AgCenter: Allegations Made by Commissioner Are Untrue
- GB Sciences Declares A "Research Revolution" At Its "2018 Innovation In Medical Cannabis Therapies" Symposium
- GB Sciences and The Colorado Hemp Project Sell First Hemp Crop for $0.7 Million Dollars
- Dr. Andrea Small-Howard, GB Sciences' Chief Science Officer, Introduces, "Unique Methods to Identify Strong Lead Compounds" at the International Cannabinoid Derived Pharmaceutical Summit
- GB Sciences and Louisiana State University Agricultural Center Enter a Joint Research and Development Agreement for the Production of Therapeutic Cannabis Targeting Severe Medical Conditions and Diseases
- GB Sciences Co-Authors a Peer-Reviewed Article Showing that Heart Failure Can Be Mitigated, and Reversed, by Orally Administered Drugs Targeting a Cellular Cannabinoid Receptor
- GB Sciences Files First Of Its Kind Provisional Patent Application For The Treatment Of Neuropathic Pain Using Time-Released, Myrcene-Based Nanoparticles
- More From Meredith Patterson, GB Sciences' Brain Nurse, As She Examines the Workings of CBD
- GB Sciences Expands into the Oklahoma Medical Cannabis Market
- Meredith Patterson, GB Sciences' Brain Nurse, Examines the Workings of CBD
- GB Sciences Sponsors "2018 Innovation In Medical Cannabis Therapies" Symposium
